Literature DB >> 23361982

Mathematical investigation of how oncogenic ras mutants promote ras signaling.

Edward C Stites1, Kodi S Ravichandran.   

Abstract

We have used a mathematical model of the Ras signaling network to link observable biochemical properties with cellular levels of RasGTP. Although there is abundant data characterizing Ras biochemistry, attributing specific changes in biochemical properties to observed phenotypes has been hindered by the scope and complexity of Ras regulation. A mathematical model of the Ras signaling module, therefore, appeared to be of value for this problem. The model described the core architecture shared by pathways that signal through Ras. Mass-action kinetics and ordinary differential equations were used to describe network reactions. Needed parameters were largely available in the published literature and resulted in a model with good agreement to experimental data. Computational analysis of the model resulted in several unanticipated predictions and suggested experiments that subsequently validated some of these predictions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23361982     DOI: 10.1007/978-1-61779-833-7_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  A systems mechanism for KRAS mutant allele-specific responses to targeted therapy.

Authors:  Thomas McFall; Jolene K Diedrich; Meron Mengistu; Stacy L Littlechild; Kendra V Paskvan; Laura Sisk-Hackworth; James J Moresco; Andrey S Shaw; Edward C Stites
Journal:  Sci Signal       Date:  2019-09-24       Impact factor: 8.192

2.  Cooperation between Noncanonical Ras Network Mutations.

Authors:  Edward C Stites; Paul C Trampont; Lisa B Haney; Scott F Walk; Kodi S Ravichandran
Journal:  Cell Rep       Date:  2015-01-15       Impact factor: 9.423

3.  Mathematical Modeling to Study KRAS Mutant-Specific Responses to Pathway Inhibition.

Authors:  Edward C Stites
Journal:  Methods Mol Biol       Date:  2021

4.  Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach.

Authors:  Thomas McFall; Edward C Stites
Journal:  Cell Rep       Date:  2021-12-14       Impact factor: 9.423

5.  Quantitative Systems Pharmacology Analysis of KRAS G12C Covalent Inhibitors.

Authors:  Edward C Stites; Andrey S Shaw
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.